ALEMBIC
Back to Balance Sheet
|
ALEMBIC Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹128 Cr | ₹96 Cr | ₹90 Cr | ₹68 Cr | ₹59 Cr |
What is the latest Total Current Liabilities ratio of ALEMBIC ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹128 Cr |
| Mar2024 | ₹96 Cr |
| Mar2023 | ₹90 Cr |
| Mar2022 | ₹68 Cr |
| Mar2021 | ₹59 Cr |
How is Total Current Liabilities of ALEMBIC Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹128 Cr | 32.75 | |
| Mar2024 | ₹96 Cr | 7.31 | |
| Mar2023 | ₹90 Cr | 32.16 | |
| Mar2022 | ₹68 Cr | 14.05 | |
| Mar2021 | ₹59 Cr | - | |
Compare Total Current Liabilities of peers of ALEMBIC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALEMBIC | ₹2,399.8 Cr | 2.4% | -7.3% | -23.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,329.0 Cr | -0.2% | -6.3% | -8.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,674.0 Cr | 3.3% | -3.4% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,891.0 Cr | -0.7% | 3.8% | 26.3% | Stock Analytics | |
| CIPLA | ₹107,292.0 Cr | -3% | -11.8% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,184.0 Cr | 6% | -3.5% | -4.3% | Stock Analytics | |
ALEMBIC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC | 2.4% |
-7.3% |
-23.8% |
| SENSEX | 0.2% |
-3.6% |
8.6% |
You may also like the below Video Courses